Italy's Alleanza Increases Presence In Morocco
Major Italian drug wholesale group Alleanza Salute has acquired aninterest in the Moroccan drugs and medicines distribution company Sophasud, which incorporates a network of 350 African pharmacists and has a local market share of over 30%. The move follows the establishment by Alleanza of a mixed company in Portugal at the start of 1997 .
The Italian company has had a presence in the Moroccan market for some time via Atlas Repartition, controlled by Sophasud, but it has now acquired 30% of the distribution company. At present, Sophasud has bases in Marrakesh, Casablanca and Agadir and reported a 20% rise in sales for 1996.
The domestic market is regarded as buoyant, with growth of 9% annually, and a population that has a high proportion of people with Italian roots. Alleanza believes that the health care market will see rapid growth, even though Morocco has no national health service at present.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze